Generation Bio Co.

NASDAQ: GBIO · Real-Time Price · USD
6.64
0.35 (5.65%)
At close: Aug 18, 2025, 3:59 PM
6.79
2.26%
Pre-market: Aug 19, 2025, 04:28 AM EDT

Generation Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
19.89M 5.9M n/a n/a
Cost of Revenue
4.93M 5.26M 5.13M 4.53M
Gross Profit
19.89M -71.03M -5.13M -4.53M
Operating Income
-142.39M -138.56M -141.18M -119.1M
Interest Income
10.72M 11.95M 4.54M 187K
Pretax Income
-131.67M -126.61M -136.64M -119.15M
Net Income
-131.67M -126.61M -136.64M -119.15M
Selling & General & Admin
37.78M 50.85M 44.46M 33.85M
Research & Development
61.3M 93.62M 96.72M 85.25M
Other Expenses
63.2M -76.94M -70.56M -4.53M
Operating Expenses
162.28M 67.53M 70.62M 114.57M
Interest Expense
n/a n/a 4.54M 50K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
162.28M 144.47M 141.18M 119.1M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
6.66M 6.45M 5.81M 5.63M
Shares Outstanding (Diluted)
6.66M 6.45M 5.81M 5.63M
EPS (Basic)
-19.76 -19.63 -23.51 -21.17
EPS (Diluted)
-19.76 -19.63 -23.51 -21.17
EBITDA
-74.26M -133.3M -136.05M -114.57M
EBIT
-79.19M -138.56M -141.18M -119.15M
Depreciation & Amortization
4.93M 5.26M 5.13M 4.53M